The Fund’s investment objective is to seek long-term growth of capital by investing primarily in equity securities of companies located anywhere in the world and selected for their growth potential.
The Fund will invest primarily in securities of companies that have a life sciences orientation. Companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. The Fund will invest at least 25% of its total assets, in the aggregate, in the following industry groups: health care; pharmaceuticals; agriculture; cosmetics/personal care; and biotechnology. No more than 10% of the net asset value of the Fund may be invested in securities traded on any one developing market and the aggregate amount of the Fund which may be invested in securities traded on the developing markets is 20% of the net asset value of the Fund.
Why consider the fund?
Finding growth in health care
In addition to the powerful demographic trends affecting the sector, health care is also experiencing acceleration in innovation. The fund seeks to invest in growth companies that are addressing unmet medical needs or making the health care system more efficient and affordable.
Dedicated sector experts
Our dedicated team of analysts has more than 75 years of combined experience investing in health care companies. In this complex and rapidly growing sector, we believe it is critical to have an experienced team that seeks to understand both the science and the business of the companies in which they invest.
Deep and disciplined
We believe the combination of deep fundamental research and disciplined portfolio construction will lead to consistently strong results relative to both the health care sector and the broader equity market. The fund is balanced across the subsectors of health care and diversified across market-cap segments and geographies.